Core Vct I Share Discussion Threads

[donsan] 03/1/2018 10:24

All 3 POT shares doing outstanding, Aphria, Innovative Industrial Properties & Cannabix technologies, can trade these online via HL. Good luck

el Don

[fillipe] 03/1/2018 09:48

FTC - news coming?

f

[fillipe] 03/1/2018 09:45

ZOL - on the up today without any promo.

f

[cpap man] 03/1/2018 09:30

DERR



News mega on the way at DERR?!?!?

[cpap man] 03/1/2018 09:00

CLNR on fire again today!

[cpap man] 03/1/2018 08:37

UOG & PXOG



PXOG are up by circa 9% on the back of market whispers over the Italian drill [flow rates]

Time for UOG who hold a higher % to join in todays share price rises!

[cpap man] 03/1/2018 08:06

HK:0575



The old AIM listed PLE now HK:0575

[argy3] 03/1/2018 08:02

RR(.90-1.0)

Red Rock Resources - Initiation of Coverage by Align research

Conviction Buy - Price Target 2.89p

Compelling portfolio of commodity investments underpinned by RRR's stake in Jupiter Mines expected to be worth one and a half times the current market cap providing the rest for free

[nash81] 03/1/2018 00:15

platinum and palladium are racing higher.

excellent exposure for JLP

[nash81] 03/1/2018 00:15

platinum and palladium are racing higher.

excellent exposure for JLP

[cpap man] 02/1/2018 18:31

NASDAQ:GALT

[argy3] 02/1/2018 16:33

PIRI

Continuing to tick better. 'Shell' news soon?

[cpap man] 02/1/2018 16:08

CLNR



Tipped in the Evening Standard tips of the year, albeit by Algy's mate Anthony Hilton:

"Algy Cluff made his name as one of the most successful pioneers of North Sea exploration back in the 1970s. He thinks there is still a lot of gas waiting to be discovered that would be profitable to extract using modern drilling techniques.

His company, Cluff Natural Resources, has put together some promising acreage at rock-bottom prices in the southern North Sea but he needs a big, rich partner to bear the financial cost of exploiting what may be out there. If he finds one the shares could do well. If he fails, then they won’t."

[hottingup] 02/1/2018 15:23

Shares Magazine
Small caps poised for big news in 2018:
We look at 19 stocks primed to deliver major events in their career
21/12/2017



"Drug developer ImmuPharma (IMM) is expecting Phase III results in the first quarter of 2018 for lupus treatment Lupuzor. Analysts speculate the drug could hit multi-billion dollar annual sales if the tests are successful and the drug gets approved by the regulators."


This promising small-cap stock could be a millionaire maker in 2018
Paul Summers
26/12/2017



The suggestion that a single stock could lead some investors to become millionaires next year may sound fanciful but I think this is quite possible if events work out for small-cap drug discovery and development firm ImmuPharma (LSE: IMM). Let me explain.

Blockbuster potential

Over the last three months, shares in the AIM-listed company have climbed more than 200% in value as anticipation grows over the outcome of a Phase III clinical trial for Lupuzor — its 100%-owned potential treatment for Lupus.

Approximately five million people are believed to suffer from the chronic and potentially life-threatening autoimmune disease that can be a notoriously difficult to treat. In the last 50 years, only one therapy — GlaxoSmithKline‘s Benlysta — has been approved for use, despite its questionable efficacy and serious side-effects. In 2015, the drug achieved sales of over $400m. By 2020, this figure is expected to rise to $1bn.

Positively, data from Lupozor’s Phase IIb trial indicated that ImmuPharma’s treatment — which modulates rather than blocks the immune system — was both effective and safe. Moreover, the effectiveness of Lupuzor increased even after the three-month trial’s conclusion. Investors will be hoping that the 52-week, randomised and double-blinded study currently in progress (involving patients in the US, Europe and Mauritius) yields similar results.

In its most recent update on 21 December, the company revealed that all 200 participants had now received the full 12-month dosage and that the “robust safety record” shown in earlier trials continues to be seen. According to Chairman Tim McCarthy, the company looks forward “with continued confidence” to reporting on top-line results in Q1 of next year.

In the event of a positive outcome, ImmuPharma will then seek to exploit its Fast Track designation and push for approval from the Food and Drug Administration (FDA). Once received, the company would then be free to seek out a global licensing deal for taking Lupuzor to market or — perhaps more likely — consider takeover bids by deep-pocketed pharmaceutical giants at a price befitting its blockbuster potential. Given the suggestion that it could be used in the treatment of other diseases, the price could easily be in the billions of pounds. Right now, ImmuPharma’s market cap is a little over £200m.


Tim McCarthy (IMM Chairman)
14/3/2017
"There's going to be a fantastic return on investment for anybody who invests in ImmuPharma...This (Lupuzor) is going to be a multi-billion dollar drug, its as simple as that...This will absolutely be a multi-billion dollar drug."

4 min 40 sec.

[olly1972] 02/1/2018 15:16

Pvr! !!!!!!!!

[cpap man] 02/1/2018 12:49

DERR



Finally action at DERR?!?!?

[mostro] 02/1/2018 12:48

Just into DRG as something stirring.

[cpap man] 02/1/2018 11:28

CLNR



Ahead of the rumoured MEGA news with regards to a "farm out" in the North sea Algy Cluff's CLNR continues to power ahead with an increasingly interesting chart!

[argy3] 02/1/2018 11:12

RRR

Hopefully plenty of good news to come soon.

[cpap man] 02/1/2018 10:26

UOG



Good start to the NY 2018 for oil & gas play [headed up by 2 ex Tullow Oil boys] namely UOG

[cpap man] 02/1/2018 10:07

OTC



luckyPhilip2 Jan '18 - 07:43 - 879 of 881

Fantastic appointment. Jonathan de Thierry is a proven genius at extracting value from projects . It looks like ortac is increasingly being run by casa people

1savvyinvestor2 Jan '18 - 07:48 - 880 of 881

Agreed . I have personal experience of his quality as was invested in "Copperbelt " which was another small company at first with copper in Drc and was sold to the Chinese for a massive profit



yes good news indeed - OTC just need to re-name to CASA and move forwards fast whilst disposing of all the junk!